Issue 2/2001
Content (11 Articles)
A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer
Ian Olver, Margaret Davy, Diana Lüftner, So-Hyang Park, Merrill Egorin, Andrew Ellis, Lorraine Webster
Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines
Martin J. Edelman, Heather Quam, Brian Mullins
Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients
Stefanie Reif, Dorothea Kingreen, Charlotte Kloft, Jenny Grimm, Wolfgang Siegert, Walter Schunack, Ulrich Jaehde
Increased activity of CYP3A enzyme in primary cultures of rat hepatocytes treated with docetaxel: comparative evaluation with paclitaxel
Srikanth C. Nallani, Mary Genter, Pankaj B. Desai
Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model
Ping Guo, Jianguo Ma, Shaolan Li, Zhiwei Guo, Andrea L. Adams, James M. Gallo
Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial
Roy S. Herbst, Cathleen Lynch, Michael Vasconcelles, Beverly A. Teicher, Gary Strauss, Anthony Elias, Ian Anderson, Patrick Zacarola, Nam H. Dang, Traci Leong, Ravi Salgia, Arthur T. Skarin
Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice
Maria V. Papadopoulou, Ming Ji, William D. Bloomer
Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein
Cecilia H. Fu, Sagrario Martin-Aragon, Kenneth I. Weinberg, Veronica C. Ardi, Peter V. Danenberg, Vassilios I. Avramis
Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy
Omar N. Al Safarjalani, Xiao-Jian Zhou, Fardos N. Naguib, Naganna M. Goudgaon, Raymond F. Schinazi, Mahmoud H. el Kouni
Dose escalation study of irinotecan combined with carboplatin for advanced non-small-cell lung cancer
Koji Takeda, Shunichi Negoro, Nobuhide Takifuji, Takashi Nitta, Naruo Yoshimura, Kazuhiko Terakawa, Masahiro Fukuoka
Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer
Pankaj Bhargava, John L. Marshall, Karen Fried, Marion Williams, Patricia Lefebvre, William Dahut, John Hanfelt, Edmund Gehan, Manuela Figuera, Michael J. Hawkins, Naiyer A. Rizvi